Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients

Roniel Cabrera, Miguel Ararat, Consuelo Soldevilla-Pico, Lisa Dixon, Jen Jung Pan, Roberto Firpi, Victor Machicao, Cynthia Levy, David Nelson, Giuseppe Morelli

Research output: Contribution to journalArticle

45 Scopus citations

Abstract

In transplant recipients transplanted for hepatitis C, presentation of abnormal transaminases can herald the presentation of recurrent hepatitis C, cellular rejection, or both. Given the sometimes ambiguous histology with these 2 entities, the ability to distinguish them is of great importance because misinterpretation can potentially affect graft survival. We used an immune functional assay to help assess the etiology of abnormal liver function test results in liver transplant recipients. Blood samples for the immune functional assay were taken from 42 recipients prospectively at various times post-transplant and compared with clinical and histologic findings. In patients whose liver biopsy showed evidence of cellular rejection, the immune response was noted to be very high, whereas in those with active recurrence of hepatitis C, the immune response was found to be very low. This finding was found to be statistically significant (P < 0.0001). In those patients in whom there was no predominant histologic features suggesting 1 entity over the other, the immune response was higher than in those with aggressive hepatitis C but lower than in those with cellular rejection. In conclusion, these data show the potential utility of the ImmuKnow assay as a means of distinguishing hepatitis C from cellular rejection and its potential usefulness as a marker for outlining the progression of hepatitis C.

Original languageEnglish (US)
Pages (from-to)216-222
Number of pages7
JournalLiver Transplantation
Volume15
Issue number2
DOIs
StatePublished - 2009

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation

Fingerprint Dive into the research topics of 'Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients'. Together they form a unique fingerprint.

  • Cite this

    Cabrera, R., Ararat, M., Soldevilla-Pico, C., Dixon, L., Pan, J. J., Firpi, R., Machicao, V., Levy, C., Nelson, D., & Morelli, G. (2009). Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Liver Transplantation, 15(2), 216-222. https://doi.org/10.1002/lt.21666